Innovate Biopharmaceuticals

YTD

ALL

Why Robinhood?

You can watch INNT and buy or sell other stocks, ETFs, and their options commission-free!

About INNT

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.

CEO

Bethany L. Sensenig, MBA

CEOBethany L. Sensenig, MBA

Employees

—

Employees—

Headquarters

Raleigh, North Carolina

HeadquartersRaleigh, North Carolina

Founded

2012

Founded2012

Employees

—

Employees—

INNT Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

17.78

Average volume17.78

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0005

52 Week high$0.0005

52 Week low

—

52 Week low—

Stock Snapshot

As of today, Innovate Biopharmaceuticals(INNT) shares are valued at $2.05. The company's market cap stands at 100.

During the trading day, Innovate Biopharmaceuticals(INNT) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Innovate Biopharmaceuticals(INNT) stock has reached 0, versus its average volume of 17.78.

People also own

Based on the portfolios of people who own INNT. This list is generated using Robinhood data, and it’s not a recommendation.

Biocept

BioPharmX

Titan Pharmaceuticals

Inpixon

Onconova Therapeutics

Hexo

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.